6-APB

Share on Facebook Share on Twitter Email
6-APB
Systematic (IUPAC) name
6-(2-aminopropyl)benzofuran
Clinical data
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 286834-85-3 N
286834-84-2 (hydrochloride)
ATC code None
PubChem CID 9794343
ChemSpider 7970110 YesY
Chemical data
Formula C11H13NO 
Mol. mass 175.23 g/mol
SMILES eMolecules & PubChem
 N (what is this?)  (verify)

6-(2-aminopropyl)benzofuran or 1-benzofuran-6-ylpropan-2-amine (6-APB or Benzo Fury) is thought to be a stimulant and entactogen drug although to date, no authoritative source can say even whether or not it is psychoactive. It was first identified being sold as a designer drug in 2012.[1] Chemically, it is of the phenethylamine and substituted amphetamine classes. It is similar to MDA in that the 3,4-methylenedioxyphenyl ring system has been replaced with a benzofuran ring. 6-APB is also the unsaturated benzofuran derivative of 6-APDB. There is currently no toxicology data available.

Contents

Pharmacology

6-APB has not been properly assessed in terms of pharmacological action, but based on its chemical similarity to other amphetamines and methylenedioxy compounds, it likely acts as a releasing agent and reuptake inhibitor of serotonin, norepinephrine, and dopamine.[citation needed] Though its effects on monoamine release have not been validated, 6-APB has been claimed to act as an agonist of the 5-HT2C receptor.[2] It may also act as an agonist of the 5-HT2A and 5-HT2B receptors, the former likely explaining its reputed psychedelic effects.

Law

6-APB is not listed under the Opium Law or the Medicine Act in the Netherlands, and thus currently legal.

6-APB is unscheduled in the United States. However, this chemical may be covered under the Federal Analogue Act in the United States.

Certain countries contain a "substantially similar" catch-all clause in their drug law, such as New Zealand and Australia. This includes 6-APB as it is in some respects similar in chemical structure to the class A drug MDA[citation needed], meaning 6-APB may be viewed as a controlled substance analogue in these jurisdictions.[3]

6-APB is unscheduled under the Controlled Drugs and Substances Act (CDSA) in Canada, although there is a Schedule III amphetamine analogue clause. Due to 6-APB's structure, it may be considered an analogue of MDA, but these types of offenses are rarely prosecuted.[citation needed] Canada's CDSA defines an analogue as any substance that, in relation to a controlled substance, has a substantially similar chemical structure.

6-APB is currently legal in the UK.

6-APB is currently legal in Germany. If consumption is intended however, the German drug law takes effect automatically, prohibiting production and disposal.[4]

See also

References

  1. ^ Shanks KG, Dahn T, Behonick G, Terrell A. Analysis of First and Second Generation Legal Highs for Synthetic Cannabinoids and Synthetic Stimulants by Ultra-Performance Liquid Chromatography and Time of Flight Mass Spectrometry. Journal of Analytical Toxicology. 2012 May 14. PMID 22586208
  2. ^ US patent 7045545, Karin Briner et al, "Aminoalkylbenzofurans as serotonin (5-HT(2c)) agonists", published 2000-01-19, issued 2006-16-03 
  3. ^ "Misuse of Drugs Act 1975 New Zealand.". legislation.govt.nz. Archived from the original on 28 July 2010. http://www.legislation.govt.nz/act/public/1975/0116/latest/DLM436101.html. Retrieved 2010-08-06. 
  4. ^ http://www.bfarm.de/DE/Bundesopiumstelle/BtM/sachverst/functions/sachverst-node.html

[Synthesis:http://www.xfactorchemicals.com/images/synthesis/6-apb-benzo-fury-synthesis-.html]


Post a question - any question - to the WikiAnswers community:

Copyrights: